Measles, Mumps and Rubella Vaccine (Live) (Serum Institute Of India)

麻疹、腮腺炎、风疹三联减毒活疫苗 (Serum Institute Of India)

Report date: 2022/09/05 10:45:21

Base Information

Drug NameMeasles, Mumps and Rubella Vaccine (Live) (Serum Institute Of India)
Drug Alias NameTRESIVACTriviratenTriviraten Berna
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Combination vaccineVaccines > Development/production technology > Live attenuated vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsParotitisRubellaMeasles
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndiaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaNDA/BLA
Originator CompaniesSerum Institute Of India LtdHard To Treat Diseases
China Registration ClassN/A

Develop Information

Active CompaniesShen Zhen Mellow Hope Pharm Industrial Co LtdSerum Institute Of India Ltd
Inactive CompaniesN/A
Active IndicationsParotitisRubellaMeasles
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A